chrisvoncsefalvay/vaers-outcomes huggingface dataset:
9cm x 12cm erythematous, macular, warm rash at site of Varicella vaccine administration (right upper arm) approximately 24 hours after vaccine administration.
I fell while helping my neighbor move a box into her apartment. When I tried to get back up, I found I had no strength in my left arm.
This spontaneous report as received from a other health professional refers to a 6 year old patient. On 19-AUG-2014 the patient was vaccinated with an expired PNEUMOVAX23 (strength and route not reported) lot# H020684. No adverse effects reported. Additional information is not expected because the reported refused additional contact.
Fever and chills starting 12 hours after injection. Temperature 101.7 then and now 5 hours later! Unable to sleep, restlessness! Lower legs itch. Site is sore! Had been to to not take ibuprofen or Tylenol to help antibodies form!  Can I take Benadryl? I had none of these adverse effects with 1st dose!
This spontaneous report as received via a company representative from a pharmacist refers to a patient of unknown age and gender with no reported medical history. On 31-OCT-2013 (reported as 2 weeks ago) the patient was vaccinated with ZOSTAVAX (route, dose and lot number unknown). No other suspect therapy or concomitant medication was reported. On an unspecified date in November 2013 (reported as since been diagnosed, on an unspecified date) the patient experienced active shingles. The unspecified patient returned to the pharmacy on an unspecified date to fill a prescription for an unspecified cream that was prescribed by an unspecified healthcare provider to help with itching from shingles. The outcome of active shingles is unknown. The reporters relatedness of active shingles to ZOSTAVAX is unknown. Additional information has been requested.
day after vaccine had large painful red lump  took Benadryl & placed ice on it, 2 days after vaccine , bump gone but whole  upper arm & swollen & painful arm with movement to streaks
Pt given 3rd dose of Pfizer COVID-19 vaccine earlier than CDC recommendation. The state vaccine registry incorrectly stated patient was due for next dose.
I had nausea, upset stomach, diarrhea and extreme exhaustion. I had body pains that kept moving throughout my entire body. For three months these lasted and I'm still experiencing some of them. I still have diarrhea and exhaustion. I was at the ER at the hospital - once and they didn't do anything. This is my fibromyalgia symptoms exacerbated because of COVID vaccine. I have seen my neurologist and he was the one that diagnosed this.
Redness, swelling, tenderness at site of injection, warm to touch for 1 day.
Fever of 102 degrees F, nausea, vomiting,  fatigue,  muscle aches. Treated with IB profin, symptoms resolved in 24 hours.
Tingling of legs, right leg more than left. Hot/Cold sensation that started today 8/12/21 @11am.  Called PCP today at 1636. Awaiting call back.
Ringing in ears Sinus congestion  Bad headache Aches and pains in joints Fatigue
Headache, Myalgia, Arthralgia, Fever, chills, fatigue, muscle pain, joint pain, Narrative:
Found to be COVID-19 positive, altered mental status and symptomatic with O2 requirement. Treated with one 200mg dose of remdesivir and dexamethasone 6mg IV daily x 5 days. Oxygen delivered via nasal cannula and SO2 remained over 90% (and mostly over 95%) the entire admission. Acute encephalopathy and Seizure, possible, post-dialysis versus dialysis disequilibrium syndrome occurred during this admission and was the reason for time spent in the ICU (~24 hours).
on march 18 2021  I had numbness on left side of body starting from tongue & cheek to the left foot.  Dr said scan of head was clear I have history of stroke  .  Numbness lasted 2 hours  I was in hospital over night .  is this a known side effect of vaccaine?    should I gat second dose?
Case number PHEH2014US011159 is an initial spontaneous report received from a nurse sales representative on 29 May 2014. This report refers to a patient whose identifiers were not reported. The patient's medical history and concomitant medications were not reported. The patient was vaccinated with MENVEO (batch number: not reported) intramuscularly on an unknown date. It was reported that the patient only received MenA lyophilized powder component reconstituted with sterile water and did not receive MEnCYW-135 liquid conjugate. The physician's office had an extra liquid vial of MENVEO. No adverse events were reported following the maladministration. No further information was provided.
Events: Infantile spasms, seizures; treatment: ACTH, Zantac; outcome: unknown at this time.
Muscle aches (flu like). Onset approx 12 hours after receiving vaccine, and lasted until morning of 4/2/21  Muscle pain at injection site. Onset approx 8 hours after receiving vaccine, lasting until morning of 4/2/21  Tx with OTC acetaminophen and naproxen
4 centimeter indurated, mildly tender, non-erythematous nodule on right deltoid fever 102.
One week after TD vaccination left arm began to swell - extended down arm to hand and up over shoulder - 2 wks went to M.D. received steroid injection - continued to spread - contacted office reported 2-22-07 - Encourage to return to M.D. - rash had spread around breast. MD Rx for medicine (pill) for itching and continued use of hydrocortisone cream. No report of diagnosis of injection.
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. ON 27-AUG-2015, the patient was vaccinated with an expired dose of RECOMBIVAX HB (lot number reported as 1205AA and expiration date 01-APR-2014) (dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effect was reported. Additional information has been requested.
Patient unresponsive; presented with seizure like activity; Patient fall from chair within 15minutes of receiving Pfizer vaccine dose 1; pale; diaphoretic; nausea; Full body clonus; This is a spontaneous report from a contactable nurse. A 26-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection) (at 26 years of age), dose 1 intramuscular, administered in arm left on 03Apr2021 10:45 (Batch/Lot Number: ER8737) as a single dose for COVID-19 immunisation. The patient's medical history included penicillin allergy. The patient's concomitant medications were not reported. The patient had no other vaccine prior to Covid vaccine. He was not diagnosed with COVID-19 prior to vaccination. It was unknown if patient has been tested for COVID-19 since the vaccination. It was reported that the patient fell from  chair within 15 minutes of receiving Pfizer vaccine dose 1. Patient was unresponsive, pale, diaphoretic. Awakened within minutes, placed in recovery position on left side. Patient complained of nausea then presented with seizure like activity. Full body clonus. 911 notified. Patient woke within seconds able to state, name, location, date of birth accurately. He was placed on stretcher. EMS arrived. VS 154/80 HR 84, POx99% 2LO2. He continues to be pale. Family of patient notified of event at patient's request. He was transferred to ED via EMS. The events started on 03Apr2021 at 10:45 AM (as reported). Therapeutic measures were taken as a result of the events. The outcome of the events was unknown. Additional information has been requested.; Sender's Comments: Bases on the information in the case report and a strong temporal relationship, A causal relationship between adverse events Unresponsive to stimuli, Seizure and suspect product BNT162B2 cannot be excluded.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Ewing Sarcoma in 3 tumor surrounding right lung; fever; persistent cough; Pleural effusion; scoliosis; This is a spontaneous report from a contactable consumer (patient). This 14-year-old female patient received the second dose of  BNT162B2 (lot number unknown) at left arm at single dose for COVID-19 immunisation on 17Jun2021 at 15:00. Relevant history included known allergies to Etoposide chemo medicine. Relevant concomitant drug was unknown. The patient previously received the first dose of BNT162B2 for COVID-19 immunisation on 27May2021 at 15:00  at left arm. The patient was not pregnant. The patient was  diagnosed as scoliosis in Jul2021.  On 16Aug2021, the patient experienced persistent cough and fever, then emergency visit to hospital for pleural effusion from lung cavity and diagnosis of Ewing Sarcoma in 3 tumor surrounding right lung.  The events resulted in Emergency room/department or urgent care.  The patient was hospitalized for 35 days. The events were considered as life-threatening.  Treatment therapy included Chemotherapy. The outcome of event scoliosis was unknown. The outcome of other events was not resolved. Lab tests included Covid-19 RT-PCR test on 20Aug2021 with negative result (Nasal Swab),  COVID-19 PCR COMBO on 10Sep2021 and on 27Oct2021, both with negative result (Nasal Swab), RAPID SARS-COV-2 on 13Oct2021 with negative result (Nasal Swab).  The patient did not receive any other vaccines within 4 weeks prior to the COVID.  The patient did not receive any other medications within 2 weeks of vaccination.  Prior to vaccination, the patient was not diagnosed with COVID-19.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
A week after injection I developed a fairly large area (6" long by 3" wide) with erythemia, mild swelling, and accompanying pruritis, and with scattered petechiae around the injection site on my upper left arm. Still present three days later but resolving. It was not sufficient to cause any difficulty with my daily activities and did not require any medical intervention. I did apply 1% hydrocortisone cream with no significant effect. I just wanted to report it because this is a new vaccine, and I wanted to make sure any side effect was noted for research purposes.
Myocarditis followed by deteriorated heart valves resulting in open heart surgery for aorta and mitral valve replacement.  Surgery in June 2022.
Allergic rash (hives) broke out behind ears and on neck of child. Benadryl (children's) given for relief of itching
Dose 1 -- Adverse effects included extreme soreness at injection site; hot, red skin at injection site ( a circle of approximately 3-4 inches in diameter0; occasional itchiness of skin within the circle. Duration of above effects = approx 5 days after injection. Dose 2 -- Same effects as w/Dose 1 PLUS additional effects:  On Day 2,  noticeable fatigue/listlessness  as well as low-grade fever (normal temp = approx 97.3 (I get checked at work so this is pretty consistent) and on Day 2, I registered 99.5 deg F.  Fever broke around 11 pm.  Side effects of arm soreness diminished sooner, at approximately 3 days.  Redness, hotness & itchiness continued longer (about 5 days)
Diarrhea; sore arm; Nausea; really tired; This is a spontaneous report from a contactable consumer (patient) from a Pfizer-sponsored program. A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number: EM9809, Expiration Date: not reported), via an unspecified route of administration, administered in right arm on 14Feb2021 at 14:00 (at the age of 55 years old) as dose 1, single for COVID-19 immunisation. Medical history included unspecified allergies and asthma - both diagnosed as a kid from an unknown date. There were no concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Historical vaccine included flu shot given on an unspecified date in Oct2020 (at the age of 55 years old) for immunization. On 15Feb2021, the patient experienced sore arm, nausea and had been really tired. Then on 16Feb2021, the patient had diarrhea and was nausea but no fever. The events did not require visit to an emergency room nor to Physician Office Visit. The patient was asking if she should expect the same side effects during the second dose and if it will be worse and was also asking if these maybe related to her allergies. Furthermore, the patient heard that the symptoms after the second dose could be worse and wanted to know what she can expect, if that is true. The patient recovered from diarrhea on 16Feb2021 and was recovering all other events.  No follow-up attempts are possible. No further information is expected.
Patient reports symptoms of right hand numbness and weakness and slurred speech.  These occurred around 7:30 pm but it is unclear exactly what day they happened as one physician noted the day of the vaccine and another noted 2 days after the vaccine.  The slurred speech resolved in 5 minutes but the hand continued to have some numbness and tingling.  Patient was referred to the neurologist who diagnosed a TIA and ordered further workup.  Patient was found to have calcified plaques in the left proximal internal carotid artery with severe stenosis.  She was referred to vascular surgery for an endarterectomy.  During the process of clearing her for surgery she was seen by a cardiologist who requested that this event be reported to VAERS.
?Pfizer-BioNTech COVID-19 Vaccine EUA?  Vaccine administration error related to temperature excursion from recommended storage temperature, not known to this writer to be associated with an adverse event. The clinic has relayed to this writer that prior to the vaccine's thawing and administration to the vaccine recipient, the administered vaccine was stored in frozen temperatures for longer than recommended by the manufacturer. (This VAERS writer assigned to form completion was not the administrator of this vaccine.)   Outcome: Vaccine recipient contacted by staff.
acute brachial plexopathy 3mo p/vax & 2wk p/vax;
Starting 8/31 - Rash and Swelling of the legs (red circle with striations) on both legs the size of of an orange for a week, then it went away, and there's only a single spot the size of a quarter on each leg now. Self resolving. Patient also has had nerve pain that's shooting up from her knee up to her hip, but given gabapentin at the ER but it has not been helping. Patient's usual oxycodone that she gets for her arthritis isn't helping either.  9/5 - left hand was swollen like a blown up latex glove, patient was unable to move fingers of hand. Patient was seen on day 1 of hand symptoms by urgent care and referred to ER and was given cephalexin , and the swelling went down after 4 days. ER Dr stated it can possibly be cellulitis. Patient's blood pressure was measured at urgent care and it was 187/97. Patient has never been diagnosed with high blood pressure before, previously patient had always been 120/80.  9/11 - patient's blood pressure has been high since measuring at her doctor's office as 168/88. circular rash (swollen and hard) has occurred on her right forearm the size 6 inches in length, 3-4 inches in width. Patient's PCP (who doesn't believe that the patient should have been given shingrix in the first place) believes it's also cellulitis.   9/12 - measured patient's blood pressure as well and it measured at 148/88. patient's forearm rash has doubled in size since the markings made yesterday.
Rapid heart beat; spinning intermittent; off balance leaning left; slow to breath; Appetite; Weakness; Fatigue; Blackout; Nausea; Dizzy/ room spinning; A spontaneous report was received from a consumer ( concerning an 88-year-old, patient of unknown gender who received Moderna's COVID-19 vaccine (mRNA-1273)  and experienced blackout, dizziness, nausea, fatigue, room spinning counter clockwise, loss of appetite, weakness, rapid heartbeat, spinning intermittent, off balance leaning left and slow breath.    The patient's medical history was not provided.  Concomitant product use was not provided by the reporter.    On 3FEB2021, approximately 2 days prior to the onset of the symptoms, the patient received their first of two planned doses of mRNA-1273 (Batch number:013ML0A) intramuscularly for prophylaxis of COVID-19 infection.     On 5 Feb2021,the patient became dizzy. On 6 Feb 2021, the patient experienced blackout and nausea.. On 7 Feb 2021, the patient experienced fatigue. The next day, on 8 Feb 2021,the patient had loss of appetite and weakness .On 10 Feb 2021, the patient had rapid heartbeat, spinning intermittent, off balance leaning left and slow to breath. Treatment information was not provided.     The outcome of the events was unknown/not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the reported events, a causal relationship cannot be excluded. Nausea and fatigue are consistent with the known safety profile of mRNA-1273.
On July 20, 2022, the patient received the Hep A Pedi vaccine in error rather than the Adult Hep A. Upon discovery of the error, the patient was called on July 22 at 12:15 pm and a voicemail was left. The call was returned at 8:45 pm and I explained the incident to the patient.  The patient did not report any unusual symptoms or reactions. We will continue to monitor the patient by phone communication for the next 3 days.  The patient will need to return for re-vaccination with the Hep A adult vaccine. She will return to the clinic on July 27, 2022.
Over 42 days since the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 42 days since the first dose) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included Insulin BASAGLAR and VICTOZA for Diabetes.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 42 days since the first dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Over 42 days since the first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Concomitant product use was not provider by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 28-Jun-2021: Follow-up received on 28-JUN-2021 contains no new information.
bad symptoms 6 days after 2nd vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (bad symptoms 6 days after 2nd vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (bad symptoms 6 days after 2nd vaccine). At the time of the report, VACCINATION COMPLICATION (bad symptoms 6 days after 2nd vaccine) outcome was unknown.            Action taken with vaccine was not applicable.  No concomitant medication was reported.  No treatment information was provided.
Saturday, 2/13/21   7;00 am. chills, fatigue, nausea  11:00 am-3:00pm, vomiting 3 times, fever of 100 degrees ( normal temperature is 97.5) 6pm - 6:00 am.  Fever spiking to 102.7 throughout night Sunday, 2/14/21 Fatigue and weakness. Increased pain at injection sight.
Chills; Fever; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.  On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.   On 09-Feb-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea).   At the time of the report, CHILLS (Chills), PYREXIA (Fever), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown. Not Provided    Concomitant product use was not provided by the reporter. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
My arm is aching and it is feeling that my arm is squeezing; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "My arm is aching and it is feeling that my arm is squeezing".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Pt recv vax on 9/15/98; on 9/18/98 pt exp red/ hard vax site area; dx=infection; tx=Augmentin
CLIENT RECEIVED VACCINE ON FRIDAY-08/19/2022. CLIENT CAME IN IT WAS NOTED THAT HE HAS A RAISED AREA ON OVER THE SITE AND IT EXTEND  ATL 4 X 5 IN INCHES . SITES IS RED IN COLOR and redden , hard to touch small bumps is around area.
10 days after receiving the Moderna booster shot, I developed spontaneous urticaria: I am experiencing extreme hives and itchiness all over my body for about 45 minutes until it passes, and then it will return in another area in about an hour. It results in large welts and hives that pop up in the itchy area as well as hives and streaky redness. This is only stopped by taking Claritin or Benadryl.